• Developing Strategic Partnerships: PE/VC/Family Office/High-Net Worth Investors
• In charge of capital acquisition and management (e.g. reviewing from start to finish investment allocation and review process)
• Assist with Deal Flow (Sourcing, Specialization and Evaluation)
• Developing fund value proposition infrastructure and investor attractiveness strategy
• Involved in portfolio company development
• Institutional Investor Relationship

• Advising CEO and Board corporate vision/mission and governance.
• Helping to develop corporate strategy and market dynamics in the medicinal cannabis space.
• Working with the CEO to create and report on business plans, and monitoring company health.
• Responsible for investment relations between Sanare and the investment community.
• Working with CEO/Founder to develop commercial strategy and ultimately exit plans.

• Providing commercial strategic advice and findings to CEO/Chairman and board members.
• Provide direction on all business development/global relationships within company objectives/vision.
• Responsible for investment relations between Dovizia and the investment community.
• Responsible for capital fundraising and maintaining liquidity in the company.
• Maintaining healthy relationships between the United States and Nigerian pharma business sectors.
•

• Assist CEO in seeking corporate investments, acquisition opportunities and commercial opportunities
• Build corporate infrastructure processes: board building, governance planning, new market entry
• Build marketing infrastructure (brand awareness, value prop) and investor attractiveness strategy
• Secure seed round funding and establish investor relations strategy with VC/PE/Family Office Investors

• Angel/LP/VC
• Strategic Partnerships: PE/VC/Family Office (Capital Formation/Fundraising/Exit Strategy
• Facilitation Mergers & Acquisition
• Commercial Operations Strategies: Pricing, Profit Margin Management, Valuation Strategies
• Value Proposition Infrastructure and Investor Attractiveness Strategy
• Identify and grow relationships within VC/PE/Hedge Fund community
• Help with taking companies take to IPO status and/or acquisition.

• Providing thought leadership expertise in the spaces of Healthcare, Consumers Products, and Chemicals.
• Pharmaceutical and Medical Device expertise and input.
• Whitepaper delivery on life sciences market dynamics and emerging markets.
• Life Sciences market investments expertise and Pricing/Valuation strategies expertise advice.
• Collaboration on McKinsey & Company business journals and online presence.

• Help build startup nonprofit from ground level to official 501 3(c)
• Created vision, mission and core messaging for the organization
• Built the entire board governance processes (e.g. bylaws, organization policies, term limits etc)
• Set strategy and direction for the organization. Created 5-year business plan.
• Created to cultivate relationships with key donors, and drive new donor membership.

• Developed, coached and led a global sales group of VPs, Directors and individual sales reps across 12 countries, built best in class business strategies that produced new business channels, new customer market penetration, and increased revenue growth opportunities
• Built and implemented a market customer segmentation plan that achieved a 98% top line revenue growth with wholesale/distributor accounts for new product Closamectin Pour-On and achieved organizational budget of $700 million

• As operations head, instituted SFE tools (Implemented Cognos Powerplay, Siebel and Edge Program) and increased sales personnel performance (before implementation 89% after implementation 119%
• Building and executing territory analytics, call planning, customer segmentation processes for 3 categories of business (Hemophilia-Oncology/ Woman’s Healthcare/ Growth Hormone)

• Developed comprehensive strategic marketing and training initiatives for hospital & account base sales forces (total of 1000 field personnel)
• Led the development of training/product core messaging and market research utilizing process excellence principles (e.g. KOL development, CRNA/Anesthesiology Focus Groups/Customer Segmentation Studies)